Search Legislation

Commission Implementing Regulation (EU) 2018/659Show full title

Commission Implementing Regulation (EU) 2018/659 of 12 April 2018 on the conditions for the entry into the Union of live equidae and of semen, ova and embryos of equidae (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes to legislation:

There are currently no known outstanding effects by UK legislation for Commission Implementing Regulation (EU) 2018/659, SECTION 5. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

SECTION 5U.K.General requirements for the testing and vaccination of equidae intended for entry into [F1Great Britain] and of donor equidae whose semen, ova or embryos are intended for entry into [F1Great Britain]

Article 11U.K.General requirements for laboratory testing for the certification of consignments of equidae, or their semen, ova or embryos intended for entry into [F2Great Britain]

1.The competent authority of the third country dispatching equidae or semen, ova or embryos of equidae, which are intended for entry into [F3Great Britain] shall ensure that the laboratory tests provided for in the health certificates [F4, in the form published by the appropriate authority from time to time,] for glanders, dourine, equine infectious anaemia, Venezuelan equine encephalomyelitis, Western and Eastern equine encephalomyelitis, Japanese encephalitis, West Nile Fever, vesicular stomatitis, equine viral arteritis and contagious equine metritis meet at least the sensitivity and specificity requirements laid down for the disease concerned in the respective Chapter of Section 2.5 of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, latest edition, of the World Organisation for Animal Health (OIE).

2.The competent authority of the third country dispatching equidae which are destined for [F5Great Britain] shall ensure that the laboratory tests provided for in the health certificates [F6, in the form published by the appropriate authority from time to time,] for African horse sickness are carried out in accordance with [F7the procedures described in] Annex IV to Directive 2009/156/EC.

3.The competent authority of the third country dispatching equidae or semen, ova or embryos of equidae, which are destined for [F8Great Britain] shall ensure compliance with the following:

(a)the tests referred to in paragraphs 1 and 2 are carried out in a laboratory recognised by the competent authority in the third country of dispatch;

(b)the details of sampling and the results of the tests are stated as required in the health certificate [F9for the consignment concerned, in the form published by the appropriate authority from time to time,] based on the laboratory report made available to the certifying official veterinarian.

Textual Amendments

[F10Article 12U.K.Testing upon arrival in Great Britain

Where a test carried out by, or on behalf of, the appropriate authority, on a sample taken in accordance with Commission Implementing Regulation (EU) 2019/2130, does not confirm the result of a laboratory test attested in a health certificate, in the form published by the appropriate authority from time to time, accompanying equidae or semen, ova or embryos of equidae arriving in Great Britain, the appropriate authority concerned shall ensure that the test is repeated in the national reference laboratory designated for the disease concerned in accordance with Article 4(1) of Regulation (EU) 2017/625.]

Article 13U.K.Application of vaccines and recording of vaccination

1.The competent authority of the third country dispatching equidae or semen, ova or embryos of equidae, which are destined for [F11Great Britain], shall ensure that the vaccination attested in any of the certificates [F12, in the form published by the appropriate authority from time to time,] is carried out in compliance with the following:

(a)the vaccination is carried out in accordance with the manufacturers' instructions or national legislation, whatever is stricter;

(b)the vaccination is carried out using a licensed vaccine which meets at least the requirements for safety, sterility and efficacy set out for the vaccine concerned in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, latest edition, of the World Organisation for Animal Health (OIE).

2.Where the competent authority of a third country attests that a positive laboratory finding in a serological test for African horse sickness is related to previous vaccination, the vaccination shall be documented in the identification document accompanying the equine animal, where such identification document is available.

Article 14U.K.Requirements relating to equine viral arteritis

1.Uncastrated male equidae intended for entry into [F13Great Britain], with the exception of those listed in point 1 of Annex IV, shall be subject to tests for equine viral arteritis to ascertain that their semen is free of equine arteritis virus.

2.Vaccination against equine viral arteritis, including the testing required in accordance with point 1(a) of Annex IV, shall be carried out under official veterinary supervision.

3.Vaccination against equine viral arteritis shall be valid where there is documented proof accompanying the equine animal of an uninterrupted history of a primary course carried out in compliance with one of the vaccination protocols provided for in point 1(a) of Annex IV and regular revaccination according to manufacturers' recommendations and in any event at intervals of not more than 12 months.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources